pitolisant and Spinal-Cord-Injuries

pitolisant has been researched along with Spinal-Cord-Injuries* in 1 studies

Other Studies

1 other study(ies) available for pitolisant and Spinal-Cord-Injuries

Article	Year
Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury. International review of neurobiology, 2023, Volume: 172 Topics: Antioxidants; Drug Inverse Agonism; Histamine Agonists; Humans; Nanowires; Neuroprotection; Quality of Life; Receptors, Histamine H3; Receptors, Histamine H4; Spinal Cord Injuries	2023

Article

Year

Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury.

International review of neurobiology, 2023, Volume: 172

Topics: Antioxidants; Drug Inverse Agonism; Histamine Agonists; Humans; Nanowires; Neuroprotection; Quality of Life; Receptors, Histamine H3; Receptors, Histamine H4; Spinal Cord Injuries

2023